Paul Rickard in today's Switzer newsletter suggests selling WAM as its SP has too much of a premium:
"However, portfolio performance has waned recently. Over 1 year, 3 years and 5 years it has underperformed compared to the S&P/ASX All Ordinaries Accumulation Index, and over 1 and 5 years, it has underperformed compared to the Small Ordinaries Accumulation Index. For example, in the year to 31 May, the portfolio lost 8.5% compared to a positive return of 4.7% for the All Ords, an underperformance of 13.2%. Again if management fees were included, the underperformance would be worse.
On 31 May, WAM was trading at $2.09, putting it on a massive premium of 25.9% to its NTA of $1.66. On Friday, having gone ex-dividend of 7.8c during the month, WAM was trading at $1.725."
- Forums
- ASX - By Stock
- WAM
- Ann: May 2022 Investment Update
Ann: May 2022 Investment Update, page-12
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WAM (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.52 |
Change
0.005(0.33%) |
Mkt cap ! $1.696B |
Open | High | Low | Value | Volume |
$1.51 | $1.52 | $1.51 | $340.6K | 224.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 8449 | $1.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.52 | 97366 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8449 | 1.515 |
9 | 167644 | 1.510 |
6 | 74519 | 1.505 |
22 | 200358 | 1.500 |
8 | 43500 | 1.495 |
Price($) | Vol. | No. |
---|---|---|
1.520 | 97451 | 8 |
1.525 | 28500 | 2 |
1.530 | 65175 | 5 |
1.535 | 3100 | 1 |
1.540 | 90000 | 4 |
Last trade - 12.41pm 12/11/2024 (20 minute delay) ? |
Featured News
WAM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online